Literature DB >> 15529615

The metabolic syndrome--a multifaced disease.

Maria Mota1, Camelia Pănuş, E Mota, Corina Lichiardopol, Delia Vladu, Eva Toma.   

Abstract

The metabolic syndrome (MetS) is a huge public health problem worldwide, being one of the major causes of cardiovascular disease, responsible for a growing number of premature deaths throughout the world. MetS includes a cluster of anomalies, such as: abdominal obesity, insulin resistance, hyperinsulinemia, hypertension, type 2 diabetes mellitus or glucose intolerance, hypertriglyceridemia etc. The number of people with MetS increases with age, affecting more than 40% of people in their 60s and 70s. About 30% of European people over 50 have MetS. Some experts estimate that as many as two thirds of Americans may be suffering from MetS. The exact cause of MetS is not known: genetics play a minor role, acquired in-utero factors also play a role (prenatal malnutrition, toxin exposure, exposure to high levels of maternal cortisol). For most people, the MetS results primarily from lifestyle factors, such as: chronic stress, inadequate exercise. The MetS can be avoided and reversed in most cases. Weight loss is both a treatment and goal for MetS patients. Moderate weight loss, in the range of 5-10% of body weight, can help restore body's ability to recognize insulin and greatly reduce the chance that the syndrome will evolve into a more serious illness. In most people weight loss will lower blood pressure and improve triglyceride levels. Increased activity alone can improve insulin levels. Physical activity result in a weight loss, improved blood pressure, improved cholesterol and triglyceride level and reduced risk of developing diabetes. It is also important to treat: hyperlipidemia, hypertension, prothrombotic state.

Entities:  

Mesh:

Year:  2004        PMID: 15529615

Source DB:  PubMed          Journal:  Rom J Intern Med        ISSN: 1220-4749


  3 in total

1.  Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse.

Authors:  Richard G Peterson; Charles Van Jackson; Karen M Zimmerman; Jorge Alsina-Fernandez; M Dodson Michael; Paul J Emmerson; Tamer Coskun
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

2.  Self-rated health showed a consistent association with serum HDL-cholesterol in the cross-sectional Oslo Health Study.

Authors:  Sissel E Tomten; Arne T Høstmark
Journal:  Int J Med Sci       Date:  2007-11-20       Impact factor: 3.738

3.  Role of LRP1 and ERK and cAMP Signaling Pathways in Lactoferrin-Induced Lipolysis in Mature Rat Adipocytes.

Authors:  Keiko Ikoma-Seki; Kanae Nakamura; Satoru Morishita; Tomoji Ono; Keikichi Sugiyama; Hoyoku Nishino; Hisashi Hirano; Michiaki Murakoshi
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.